Advanced search
Publication Cover
Emerging Microbes & Infections Volume 1, 2012 - Issue 1
Submit an article Journal homepage
6,887
Views
55
CrossRef citations to date
0
Altmetric
Reviews

Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem

Samson SY WongDepartment of Microbiology, Research Centre for Infection and Immunology, Faculty of Medicine, The University of Hong Kong, Hong Kong, China
&
Kwok-Yung YuenDepartment of Microbiology, Research Centre for Infection and Immunology, Faculty of Medicine, The University of Hong Kong, Hong Kong, ChinaCorrespondence[email protected]
Pages 1-10 | Received 02 Mar 2012, Accepted 16 Apr 2012, Published online: 25 Jan 2019

  • Euzéby JP. List of Prokaryotic names with Standing in Nomenclature—Genus Streptococcus. Available at http://www.bacterio.cict.fr/s/streptococcus.html (accessed 2 January 2012).
  • Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis2005; 5: 685–694.
  • Brandt CM, Haase G, Schnitzler N, Zbinden R, Lütticken R. Characterization of blood culture isolates of Streptococcus dysgalactiae subsp. equisimilis ossessing Lancefield's group A antigen. J Clin Microbiol1999; 37: 4194–4197.
  • Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev2002; 15: 613–630.
  • Oehmcke S, Shannon O, Mörgelin M, Herwald H. Streptococcal M proteins and their role as virulence determinants. Clin Chim Acta2010; 411(17/18): 1172–1180.
  • De Malmanche SA, Martin DR. Protective immunity to the group A Streptococcus may be only strain specific. Med Microbiol Immunol1994; 183: 299–306.
  • Eriksson BK, Villasenor-Sierra A, Norgren M, Stevens DL. Opsonization of T1M1 group A Streptococcus: dynamics of antibody production and strain specificity. Clin Infect Dis2001; 32: e24–e30.
  • Lancefield RC. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med1959; 110: 271–292.
  • Centers for Disease Control and Prevention. Streptococcus pyogenes emm sequence database. Available at http://www.cdc.gov/ncidod/biotech/strep/types_emm103-124.htm (accessed 31 January 2012).
  • Banks DJ, Porcella SF, Barbian KD et al. Progress toward characterization of the group A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain. J Infect Dis2004; 190: 727–738.
  • Beres SB, Sylva GL, Barbian KD et al. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci USA2002; 99: 10078–10083.
  • Beres SB, Richter EW, Nagiec MJ et al. Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci USA2006; 103: 7059–7064.
  • Ferretti JJ, McShan WM, Ajdic D et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA2001; 98: 4658–4663.
  • Green NM, Zhang S, Porcella SF et al. Genome sequence of a serotype M28 strain of group A Streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis2005; 192: 760–770.
  • Holden MT, Scott A, Cherevach I et al. Complete genome of acute rheumatic fever-associated serotype M5 Streptococcus pyogenes strain Manfredo. J Bacteriol2007; 189: 1473–1477.
  • McShan WM, Ferretti JJ, Karasawa T et al. Genome sequence of a nephritogenic and highly transformable M49 strain of Streptococcus pyogenes. J Bacteriol2008; 190: 7773–7785.
  • Nakagawa I, Kurokawa K, Yamashita A et al. Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution. Genome Res2003; 13( 6A): 1042–1055.
  • Smoot JC, Barbian KD, van Gompel JJ et al. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA2002; 99: 4668–4673.
  • National Center for Biotechnology Information (NCBI). Available at http://www.ncbi.nlm.nih.gov/genome?term=txid1314%5borgn (accessed 31 January 2012)
  • Vojtek I, Pirzada ZA, Henriques-Normark B, Mastny M, Janapatla RP, Charpentier E. Lysogenic transfer of group A Streptococcus superantigen gene among streptococci. J Infect Dis2008; 197: 225–234.
  • Sumby P, Barbian KD, Gardner DJ et al. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci USA2005; 102: 1679–1684.
  • Walker MJ, Hollands A, Sanderson-Smith ML et al. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med2007; 13: 981–985.
  • Aziz RK, Pabst MJ, Jeng A et al. Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol2004; 51: 123–134.
  • Dowson CG, Barcus V, King S, Pickerill P, Whatmore A, Yeo M. Horizontal gene transfer and the evolution of resistance and virulence determinants in Streptococcus. Soc Appl Bacteriol Symp Ser1997; 26: 42S–51S.
  • Simpson WJ, Musser JM, Cleary PP. Evidence consistent with horizontal transfer of the gene (emm12) encoding serotype M12 protein between group A and group G pathogenic streptococci. Infect Immun1992; 60: 1890–1893.
  • Jensen A, Kilian M. Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes. J Clin Microbiol2012; 50: 113–126.
  • Jönsson M, Ström K, Swedberg G. Mutations and horizontal transmission have contributed to sulfonamide resistance in Streptococcus pyogenes. Microb Drug Resist2003; 9: 147–153.
  • Pletz MW, McGee L, Van Beneden CA et al. Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer. Antimicrob Agents Chemother2006; 50: 943–948.
  • Sumby P, Porcella SF, Madrigal AG et al. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J Infect Dis2005; 192: 771–782.
  • Rato MG, Nerlich A, Bergmann R et al. Virulence gene pool detected in bovine group C Streptococcus dysgalactiae subsp. dysgalactiae solates by use of a group A S. pyogenes virulence microarray. J Clin Microbiol2011; 49: 2470–2479.
  • Shaikh N, Leonard E, Martin JM. Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics2010; 126: e557–e564.
  • Crum NF, Russell KL, Kaplan EL et al. Pneumonia outbreak associated with group a Streptococcus species at a military training facility. Clin Infect Dis2005; 40: 511–518.
  • Deutscher M, Schillie S, Gould C et al. Investigation of a group A streptococcal outbreak among residents of a long-term acute care hospital. Clin Infect Dis2011; 52: 988–994.
  • Holmström L, Nyman B, Rosengren M, Wallander S, Ripa T. Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres. Scand J Infect Dis1990; 22: 179–185.
  • Cockerill FR 3rd, MacDonald KL, Thompson RL et al. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA1997; 277: 38–43.
  • Weiss K, Laverdière M, Lovgren M, Delorme J, Poirier L, Béliveau C. Group A Streptococcus carriage among close contacts of patients with invasive infections. Am J Epidemiol1999; 149: 863–868.
  • Davies HD, McGeer A, Schwartz B et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med1996; 335: 547–554.
  • Brown WA, Allison VD. Infection of the air of scarlet-fever wards with Streptococcus pyogenes. J Hyg (Lond)1937; 37: 1–13.
  • Edward DG. Haemolytic streptococci in the dust of hospital wards, and their relationship to infection: a report to the Medical Research Council. J Hyg (Lond)1944; 43: 256–265.
  • Rammelkamp CH Jr, Morris AJ, Catanzaro FJ, Wannamaker LW, Chamovitz R, Marple EC. Transmission of group A streptococci. III. The effect of drying on the infectivity of the organism for man. J Hyg (Lond)1958; 56: 280–287.
  • Perry WD, Siegel AC, Rammelkamp CH Jr, Wannamaker LW, Marple EC. Transmission of group A streptococci. I. The role of contaminated bedding. Am J Hyg1957; 66: 85–95.
  • Wagenvoort JH, Penders RJ, Davies BI, Lütticken R. Similar environmental survival patterns of Streptococcus pyogenes strains of different epidemiologic backgrounds and clinical severity. Eur J Clin Microbiol Infect Dis2005; 24: 65–67.
  • Wilson KS, Maroney SA, Gander RM. The family pet as an unlikely source of group A beta-hemolytic streptococcal infection in humans. Pediatr Infect Dis J1995; 14: 372–375.
  • Scamman CL. Milk-borne septic sore throat and scarlet fever. Am J Public Health Nations Health1929; 19: 1339–1346.
  • Juel Henningsen E, Ernst J. Milk epidemic of angina, originating from a cow with mastitis and due to Streptococcus pyogenes (Lancefield group A). J Hyg (Lond)1938; 38: 384–391.
  • Camps FE, Miller Wood JL. An outbreak of epidemic sore-throat of milk-borne origin. Lancet1936; 228: 756–760.
  • Levy M, Johnson CG, Kraa E. Tonsillopharyngitis caused by foodborne group A Streptococcus: a prison-based outbreak. Clin Infect Dis2003; 36: 175–182.
  • Falkenhorst G, Bagdonaite J, Lisby M et al. Outbreak of group A streptococcal throat infection: don't forget to ask about food. Epidemiol Infect2008; 136: 1165–1171.
  • Katzenell U, Shemer J, Bar-Dayan Y. Streptococcal contamination of food: an unusual cause of epidemic pharyngitis. Epidemiol Infect2001; 127: 179–184.
  • Lamagni TL, Neal S, Keshishian C et al. Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003–2004. Clin Microbiol Infect2008; 14: 1002–1009.
  • Cruickshank JG, Lightfoot NF, Sugars KH et al. A large outbreak of streptococcal pyoderma in a military training establishment. J Hyg (Lond)1982; 89: 9–21.
  • Wasserzug O, Valinsky L, Klement E et al. A cluster of ecthyma outbreaks caused by a single clone of invasive and highly infective Streptococcus pyogenes. Clin Infect Dis2009; 48: 1213–1219.
  • Shulman ST, Stollerman G, Beall B, Dale JB, Tanz RR. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin Infect Dis2006; 42: 441–447.
  • Bisno AL. The resurgence of acute rheumatic fever in the United States. Annu Rev Med1990; 41: 319–329.
  • Miner LJ, Petheram SJ, Daly JA et al. Post-Streptococcal Syndrome Study Team. Molecular characterization of Streptococcus pyogenes isolates collected during periods of increased acute rheumatic fever activity in Utah. Pediatr Infect Dis J2004; 23: 56–61.
  • Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalén C; Strep-EURO. The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill2005; 10: 179–184.
  • Richardson BW. Facts relating to scarlet fever. Assoc Med J1853; 1: 502–507.
  • Rolleston JD. The history of scarlet fever. Br Med J1928; 2: 926–929.
  • Brownlee J. The relationship between rainfall and scarlet fever. Proc R Soc Med1923; 16(Sect Epidemiol State Med): 30–34.
  • Duncan CJ, Duncan SR, Scott S. The dynamics of scarlet fever epidemics in England and Wales in the 19th century. Epidemiol Infect1996; 117: 493–499.
  • Anonymous. Epidemiology of scarlet fever. Br Med J1944; 1: 118–119.
  • Perks EM, Mayon-White RT. The incidence of scarlet fever. J Hyg (Lond)1983; 91: 203–209.
  • Glover JA, Griffith F. An outbreak of scarlet fever at a preparatory school. Lancet1930; 216: 815–817.
  • Promedmail. Available at http://www.promedmail.org (accessed 31 January 2012)
  • Centre for Health Protection, Department of Health. Number of notifications for notifiable infectious diseases in 2011. Hong Kong. Available at http://www.chp.gov.hk/en/data/1/10/26/43/455.html (accessed 19 February 2012).
  • Beres SB, Sylva GL, Sturdevant DE et al. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci USA2004; 101: 11833–11838.
  • Carroll RK, Beres SB, Sitkiewicz I et al. Evolution of diversity in epidemics revealed by analysis of the human bacterial pathogen group A Streptococcus. Epidemics2011; 3( 3/4): 159–170.
  • Billal DS, Hotomi M, Shimada J et al. Prevalence of Streptococcus invasive locus (sil) and its relationship with macrolide resistance among group A Streptococcus strains. J Clin Microbiol2008; 46: 1563–1564.
  • Chiou CS, Wang YW, Chen PL, Wang WL, Wu PF, Wei HL. Association of the shuffling of Streptococcus pyogenes clones and the fluctuation of scarlet fever cases between 2000 and 2006 in central Taiwan. BMC Microbiol2009; 9: 115.
  • Rogers S, Commons R, Danchin MH et al. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A Streptococcus infections. J Infect Dis2007; 195: 1625–1633.
  • Metzgar D, McDonough EA, Hansen CJ et al. Local changes in rates of group A Streptococcus disease and antibiotic resistance are associated with geographically widespread strain turnover events. Virulence2010; 1: 247–253.
  • Kao CH, Chen PY, Huang FL et al. Clinical and genetic analysis of invasive and non-invasive group A streptococcal infections in central Taiwan. J Microbiol Immunol Infect2005; 38: 105–111.
  • Jing HB, Ning BA, Hao HJ et al. Epidemiological analysis of group A streptococci recovered from patients in China. J Med Microbiol2006; 55( Pt 8): 1101–1107.
  • Tse H, Bao JY, Davies MR et al. Molecular characterization of the 2011 Hong Kong scarlet fever outbreak. J Infect Dis.May 2012. doi: 10.1093/infdis/jis362.
  • Hong Kong Observatory. The Year's Weather—2011. Available at http://www.weather.gov.hk/wxinfo/pastwx/ywx2011.htm (accessed 19 February 2012).
  • Stollerman GH. Rheumatic fever. Lancet1997; 349: 935–942.
  • Rodríguez-Iturbe B, Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int2007; 71: 1094–1104.
  • Cunningham MW. Pathogenesis of group A streptococcal infections and their sequelae. Adv Exp Med Biol2008; 609: 29–42.
  • Tewodros W, Kronvall G. M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns. J Clin Microbiol2005; 43: 4369–4376.
  • Reid HF, Bassett DC, Gaworzewska E, Colman G, Poon-King T. Streptococcal serotypes newly associated with epidemic post-streptococcal acute glomerulonephritis. J Med Microbiol1990; 32: 111–114.
  • Erdem G, Mizumoto C, Esaki D et al. Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States. Clin Infect Dis2007; 45: e20–e24.
  • Zheng MH, Jiao ZQ, Zhang LJ et al. Genetic analysis of group A Streptococcus isolates recovered during acute glomerulonephritis outbreaks in Guizhou Province of China. J Clin Microbiol2009; 47: 715–720.
  • Martin JM, Barbadora KA. Continued high caseload of rheumatic fever in western Pennsylvania: possible rheumatogenic emm types of Streptococcus pyogenes. J Pediatr2006; 149: 58–63.
  • Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord2005; 5: 11.
  • The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA1993; 269: 390–391.
  • Lepoutre A, Doloy A, Bidet P et al. Microbiologists of the Epibac Network. Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol2011; 49: 4094–4100.
  • O'Brien KL, Beall B, Barrett NL et al. Epidemiology of invasive group a Streptococcus disease in the United States, 1995–1999. Clin Infect Dis2002; 35: 268–276.
  • O'Grady KA, Kelpie L, Andrews RM et al. The epidemiology of invasive group A streptococcal disease in Victoria, Australia. Med J Aust2007; 186: 565–569.
  • Tyrrell GJ, Lovgren M, Kress B, Grimsrud K. Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J Clin Microbiol2005; 43: 1678–1683.
  • Khateeb OM, Osborne D, Mulla ZD. Gastrointestinal symptomatology as a predictor of severe outcomes of invasive group A streptococcal infections. Epidemiol Infect2010; 138: 534–541.
  • Zakikhany K, Degail MA, Lamagni T et al. Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011. Euro Surveill2011; 16: pii:19785.
  • Jean C, Louie JK, Glaser CA et al. Invasive group A streptococcal infection concurrent with 2009 H1N1 influenza. Clin Infect Dis2010; 50: e59–e62.
  • Thigpen MC, Thomas DM, Gloss D et al. Nursing home outbreak of invasive group A streptococcal infections caused by 2 distinct strains. Infect Control Hosp Epidemiol2007; 28: 68–74.
  • Sanford BA, Davison VE, Ramsay MA. Fibrinogen-mediated adherence of group A Streptococcus to influenza A virus-infected cell cultures. Infect Immun1982; 38: 513–520.
  • Okamoto S, Kawabata S, Nakagawa I et al. Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice. J Virol2003; 77: 4104–4112.
  • Hafez MM, Abdel-Wahab KS, El-Fouhil DF. Augmented adherence and internalization of group A Streptococcus pyogenes to influenza A virus infected MDCK cells. J Basic Microbiol2010; 50( Suppl 1) : S46–S57.
  • Rolleston JD. Concurrent scarlet fever and chicken-pox. Proc R Soc Med1911; 4(Sect Study Dis Child): 14–16.
  • Christie AB. Epidemiology and Clinical Practice. In: Infectious Diseases. 2nd ed. Edinburgh: Churchill Livingstone, 1974.
  • Warrack JS. The differential diagnosis of scarlet fever, measles, and rubella. Br Med J1918; 2: 486–488.
  • Pichichero ME, Casey JR. Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis. Otolaryngol Head Neck Surg2007; 137: 851–857.
  • Steininger C, Allerberger F, Gnaiger E. Clinical significance of inhibition kinetics for Streptococcus pyogenes in response to penicillin. J Antimicrob Chemother2002; 50: 517–523.
  • Adam D, Scholz H, Helmerking M. Comparison of short-course (5 day) cefuroxime axetil with a standard 10 day oral penicillin V regimen in the treatment of tonsillopharyngitis. J Antimicrob Chemother2000; 45: S23–S30.
  • Mascini EM, Jansze M, Schouls LM, Verhoef J, Van Dijk H. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents2001; 18: 395–398.
  • Sriskandan S, McKee A, Hall L, Cohen J. Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes. J Antimicrob Chemother1997; 40: 275–277.
  • Goscinski G, Tano E, Thulin P, Norrby-Teglund A, Sjölin J. Release of SpeA from Streptococcus pyogenes after exposure to penicillin: dependency on dose and inhibition by clindamycin. Scand J Infect Dis2006; 38( 11/12): 983–987.
  • Minami M, Kamimura T, Isaka M, Tatsuno I, Ohta M, Hasegawa T. Clindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes. Antimicrob Agents Chemother2010; 54: 98–102.
  • Coyle EA, Cha R, Rybak MJ. Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release. Antimicrob Agents Chemother2003; 47: 1752–1755.
  • Tanaka M, Hasegawa T, Okamoto A, Torii K, Ohta M. Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis. Antimicrob Agents Chemother2005; 49: 88–96.
  • Darenberg J, Ihendyane N, Sjölin J et al.; StreptIg Study Group. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003; 37: 333–340.
  • Kaul R, McGeer A, Norrby-Teglund A et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome—a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis1999; 28: 800–807.
  • Health Protection Agency. Guidance on infection control in schools and other childcare settings. United Kingdom, 2010. Available at http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947358374 (accessed 2 January 2012).
  • National Health and Medical Research Council. Recommended minimum exclusion periods for infectious conditions for schools, pre-schools and child care centres. Australia, 2005. Available at http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/ch43poster4.pdf (accessed 2 January 2012).
  • Steer JA, Lamagni T, Healy B et al. Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK. J Infect2012; 64: 1–18.
  • Daneman N, McGeer A, Low DE et al. ; Ontario Group A Streptococcal Study Group. Hospital-acquired invasive group a streptococcal infections in Ontario, Canada, 1992–2000. Clin Infect Dis2005; 41: 334–342.
  • Breese BB. A simple scorecard for the tentative diagnosis of streptococcal pharyngitis. Am J Dis Child1977; 131: 514–517.
  • Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making1981; 1: 239–246.
  • Gerber MA, Shulman ST. Rapid diagnosis of pharyngitis caused by group A streptococci. Clin Microbiol Rev2004; 17: 571–580.
  • Wong MC, Chung CH. Group A streptococcal infection in patients presenting with a sore throat at an accident and emergency department: prospective observational study. Hong Kong Med J2002; 8: 92–98.
  • Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet2005; 365: 579–587.
  • Van de Sande-Bruinsma N, Grundmann H, Verloo D et al. ; European Antimicrobial Resistance Surveillance System Group; European Surveillance of Antimicrobial Consumption Project Group. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis2008; 14: 1722–1730.
  • Rautakorpi UM, Huikko S, Honkanen P et al.; MIKSTRA Collaborative Study Group. The Antimicrobial Treatment Strategies (MIKSTRA) program: a 5-year follow-up of infection-specific antibiotic use in primary health care and the effect of implementation of treatment guidelines. Clin Infect Dis2006; 42: 1221–1230.
  • Tan T, Little P, Stokes T; Guideline Development Group. Antibiotic prescribing for self limiting respiratory tract infections in primary care: summary of NICE guidance. Br Med J2008; 337: a437.
  • Tonkin-Crine S, Yardley L, Little P. Antibiotic prescribing for acute respiratory tract infections in primary care: a systematic review and meta-ethnography. J Antimicrob Chemother2011; 66: 2215–2223.
  • Kumar S, Little P, Britten N. Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. Br Med J2003; 326: 138.
  • Pires R, Ardanuy C, Rolo D et al. Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal. Antimicrob Agents Chemother2010; 54: 2677–2680.
  • Malhotra-Kumar S, van Heirstraeten L, Lammens C, Chapelle S, Goossens H. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin. J Antimicrob Chemother2009; 63: 886–894.
  • Montes M, Tamayo E, Orden B, Larruskain J, Perez-Trallero E. Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain. Antimicrob Agents Chemother2010; 54: 93–97.
  • Hinnerskov M, Therkildsen JM, Cordoba G, Bjerrum L. Macrolide overuse for treatment of respiratory tract infections in general practice. Dan Med Bull2011; 58: A4356.
  • Vojvodić Ž. Antimicrobial use and indication-based prescribing among general practitioners in Eastern Croatia: comparison with data from the European Surveillance of Antimicrobial Consumption project. Croat Med J2010; 51: 524–533.
  • Bergman M, Huikko S, Pihlajamäki M et al. ; Finnish Study Group for Antimicrobial Resistance (FiRe Network). Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997–2001. Clin Infect Dis2004; 38: 1251–1256.
  • Bergman M, Huikko S, Huovinen P, Paakkari P, Seppälä H; Finnish Study Group for Antimicrobial Resistance (FiRe Network). Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother2006; 50: 3646–3650.
  • Baquero F. Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? J Chemother1999; 11( Suppl 1): 35–43.
  • García-Rodríguez JA, Fresnadillo Martínez MJ. Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J Antimicrob Chemother2002; 50 ( Suppl S2): 59–73.
  • Chan JC, Chu YW, Chu MY, Cheung TK, Lo JY. Epidemiological analysis of Streptococcus pyogenes infections in Hong Kong. Pathology2009; 41: 681–686.
  • Chang H, Shen X, Fu Z et al. Antibiotic resistance and molecular analysis of Streptococcus pyogenes isolated from healthy schoolchildren in China. Scand J Infect Dis2010; 42: 84–89.
  • Liu X, Shen X, Chang H, Huang G et al. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China. Pediatr Pulmonol2009; 44: 436–441.
  • Logan LK, McAuley JB, Shulman ST. Macrolide treatment failure in streptococcal pharyngitis resulting in acute rheumatic fever. Pediatrics2012; 129: e798–e802.
  • Chironna M, Sallustio A, Esposito S et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother2011; 66: 734–737.
  • Xin D, Mi Z, Han X et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother2009; 53: 2158–2159.
  • Perez-Trallero E, Marimón JM, Montes M, Orden B, de Pablos M. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg Infect Dis1999; 5: 235–240.
  • Richter SS, Heilmann KP, Beekmann SE et al. Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003. Clin Infect Dis2005; 41: 599–608.
  • Chiappini E, Regoli M, Bonsignori F et al. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther2011; 33: 48–58.
  • Wilson GJ, Talkington DF, Gruber W, Edwards K, Dermody TS. Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review. Clin Infect Dis1995; 20: 1333–1338.
  • Imöhl M, van der Linden M, Reinert RR, Ritter K. Invasive group A streptococcal disease and association with varicella in Germany, 1996–2009. FEMS Immunol Med Microbiol2011; 62: 101–109.
  • Okamoto S, Kawabata S, Fujitaka H, Uehira T, Okuno Y, Hamada S. Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection. Vaccine2004; 22( 21/22): 2887–2893.
  • Lee SE, Eick A, Bloom MS, Brundage JF. Influenza immunization and subsequent diagnoses of group A Streptococcus-illnesses among US Army trainees, 2002–2006. Vaccine2008; 26( 27/28): 3383–3386.
  • Chaussee MS, Sandbulte HR, Schuneman MJ et al. Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections. Vaccine2011; 29: 3773–3781.
  • Weng TC, Chen CC, Toh HS, Tang HJ. Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice. J Microbiol Immunol Infect2011; 44: 418–423.
  • Hamilton SM, Bayer CR, Stevens DL, Lieber RL, Bryant AE. Muscle injury, vimentin expression, and nonsteroidal anti-inflammatory drugs predispose to cryptic group A streptococcal necrotizing infection. J Infect Dis2008; 198: 1692–1698.
  • Lesko SM, O'Brien KL, Schwartz B, Vezina R, Mitchell AA. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics2001; 107: 1108–1115.
  • Sharkawy A, Low DE, Saginur R et al.; Ontario Group A Streptococcal Study Group. Severe group a streptococcal soft-tissue infections in Ontario: 1992–1996. Clin Infect Dis 2002; 34: 454–460.
  • Aronoff DM, Bloch KC. Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A Streptococcus. Medicine (Baltimore)2003; 82: 225–235.
  • Roy S, Kaplan EL, Rodriguez B et al. A family cluster of five cases of group A streptococcal pneumonia. Pediatrics2003; 112( 1 Pt 1): e61–e65.
  • Laustrup HK, Justesen US, Pedersen C. Household transmission of invasive group A Streptococcus with necrotizing fasciitis. Scand J Infect Dis2003; 35( 6/7): 414–415.
  • Schwartz B, Elliott JA, Butler JC et al. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis1992; 15: 277–284.
  • Robinson KA, Rothrock G, Phan Q et al. ; Active Bacterial Core Surveillance/Emerging Infections Program Network. Risk for severe group A streptococcal disease among patients' household contacts. Emerg Infect Dis2003; 9: 443–447.
  • Kikuta H, Shibata M, Nakata S et al. Efficacy of antibiotic prophylaxis for intrafamilial transmission of group A beta-hemolytic streptococci. Pediatr Infect Dis J2007; 26: 139–141.
  • Brundage JF, Gunzenhauser JD, Longfield JN et al. Epidemiology and control of acute respiratory diseases with emphasis on group A beta-hemolytic Streptococcus: a decade of US Army experience. Pediatrics1996; 97 (6 Pt 2): 964–970.
  • Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis2002; 35 (8): 950–959. Erratum in: Clin Infect Dis 2003; 36(2): 243.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.